MedPath

BUCHINGER WILHELMI DEVELOPMENT & HOLDING GMBH

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Fastreset Study: Metabolic Effects of a Five-day Remotely Delivered Hypocaloric and Ketogenic Program

Not Applicable
Recruiting
Conditions
Healthy Lifestyle
Healthy Nutrition
First Posted Date
2023-04-20
Last Posted Date
2023-08-02
Lead Sponsor
Buchinger Wilhelmi Development & Holding GmbH
Target Recruit Count
64
Registration Number
NCT05821660
Locations
🇩🇪

Buchinger Wilhelmi Clinic, Überlingen, Baden-Württemberg, Germany

Oral and Gut Microbiota Changes During Long-term Fasting in Humans

Not Applicable
Completed
Conditions
Periodontitis
Healthy
First Posted Date
2022-07-08
Last Posted Date
2023-01-13
Lead Sponsor
Buchinger Wilhelmi Development & Holding GmbH
Target Recruit Count
36
Registration Number
NCT05449249
Locations
🇩🇪

Buchinger Wilhelmi clinic, Überlingen, Germany

Long-term Fasting: Multi-system Adaptations in Humans

Not Applicable
Completed
Conditions
Fasting
First Posted Date
2021-09-02
Last Posted Date
2023-02-08
Lead Sponsor
Buchinger Wilhelmi Development & Holding GmbH
Target Recruit Count
62
Registration Number
NCT05031598
Locations
🇩🇪

Buchinger Wilhelmi clinic, Überlingen, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.